Logo
x

Search

Subscribe Now

Tagrisso

Top Performing Drug – Tagrisso (October Edition)

Top Performing Drug – Tagrisso (October Edition)

  • October 26, 2023
Top 20 Prescription Drugs Based on 2021 Total Revenue

Top 20 Prescription Drugs Based on 2021 Total Revenue

  • November 10, 2022
Insights+: Breakthrough Therapy Designation by the US FDA in 2020

Insights+: Breakthrough Therapy Designation by the US FDA in 2020

  • March 11, 2021
AstraZeneca's Tagrisso (osimertinib) Receives the US FDA's Approval for the Adjuvant Treatment of Patients with Early-Stage EGFR-Mutated Lung Cancer

AstraZeneca's Tagrisso (osimertinib) Receives the US FDA's Approval for the Adjuvant Treatment of Patients with Early-Stage EGFR-M...

  • December 22, 2020
AstraZeneca Reports the Results of Tagrisso (osimertinib) in P-III ADAURA Study for the Adjuvant Treatment of Patients Early-Stage EGFR-Mutated Lung Cancer

AstraZeneca Reports the Results of Tagrisso (osimertinib) in P-III ADAURA Study for the Adjuvant Treatment of Patients Early-Stage...

  • September 21, 2020
AstraZeneca Collaborates with Daiichi Sankyo to Evaluate the Combination of Patritumab Deruxtecan (U3-1402) + Tagrisso for EGFR-Mutated Non-Small Cell Lung Cancer

AstraZeneca Collaborates with Daiichi Sankyo to Evaluate the Combination of Patritumab Deruxtecan (U3-1402) + Tagrisso for EGFR-Mu...

  • August 7, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.